Ilya M Rachman is CEO and Chairman of Immix Biopharma, Inc.. Currently has a direct ownership of 1.14 Million shares of IMMX, which is worth approximately $2.17 Million. The most recent transaction as insider was on Jun 07, 2024, when has been sold 2,600 shares (Common Stock) at a price of $2.13 per share, resulting in proceeds of $5,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M
0% 3M change
25.18% 12M change
Total Value Held $2.17 Million

Ilya M Rachman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2024
BUY
Open market or private purchase
$5,538 $2.13 p/Share
2,600 Added 0.23%
1,136,259 Common Stock
Jun 04 2024
BUY
Open market or private purchase
$5,973 $1.81 p/Share
3,300 Added 0.29%
1,133,659 Common Stock
May 20 2024
BUY
Grant, award, or other acquisition
-
218,359 Added 16.19%
1,130,359 Common Stock
May 14 2024
BUY
Open market or private purchase
$9,675 $2.25 p/Share
4,300 Added 0.47%
912,000 Common Stock
Nov 14 2022
BUY
Open market or private purchase
$5,148 $0.99 p/Share
5,200 Added 0.57%
907,700 Common Stock
Dec 20 2021
BUY
Open market or private purchase
$12,500 $5.0 p/Share
2,500 Added 0.28%
902,500 Common Stock
IMR

Ilya M Rachman

CEO and Chairman
Los Angeles, CA

Track Institutional and Insider Activities on IMMX

Follow Immix Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMMX shares.

Notify only if

Insider Trading

Get notified when an Immix Biopharma, Inc. insider buys or sells IMMX shares.

Notify only if

News

Receive news related to Immix Biopharma, Inc.

Track Activities on IMMX